AIM · AIM ImmunoTech Inc
United States · RS rating 4 · As of 2026-10-14
| Price | 0.16 USD |
|---|---|
| 1-day change | -4.8% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 10 / 7 / 3 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 15 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +37.7% |
| Sales growth Q/Q | -19.2% |
| Distance from 52-week high | +94.0% |
| Market cap (USD) | $4.2M |